InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Mattessich Antony C., Chairman & CEO. Insider active across 2 companies, notably OCULAR THERAPEUTIX, INC. Aggregated, 4 reports have been published. Total volume traded: €85k. The latest transaction was disclosed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
0186,750 shares0
Common Stock
SEC:0001104659-22-012918·
0186,750 shares0
Common Stock
SEC:0001104659-22-012918:0·
€42,3505,000 shares@ €8.46990.0021% mcap100.0% of flow
Common Stock
SEC:0001104659-21-108777·
Ideal exit: 17 May 2022 (T+270)
€42,3505,000 shares@ €8.46990.0021% mcap100.0% of flow
Common Stock
SEC:0001104659-21-108777:0·
Ideal exit: 17 May 2022 (T+270)
4 of 4 declarations
About Mattessich Antony C.
Antony C. Mattessich is the President and CEO of OCULAR THERAPEUTIX, INC. He leads the company in developing innovative treatments for eye diseases.
